Skip to main content
Veterinary Medicines

AURIZON EAR DROPS, SUSPENSION

Authorised
  • Marbofloxacin
  • Dexamethasone acetate
  • Clotrimazole

Product identification

Medicine name:
AURIZON EAR DROPS, SUSPENSION
AURIZON ωτικές σταγόνες, εναιώρημα
Active substance:
  • Marbofloxacin
  • Dexamethasone acetate
  • Clotrimazole
Target species:
  • Dog
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Marbofloxacin
    3.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dexamethasone acetate
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Clotrimazole
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Ear drops, suspension
Withdrawal period by route of administration:
  • Auricular use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA06
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Package description:
  • Box containing 1 x 20 ml bottle
  • Box containing 1 x 30 ml bottle
  • Box containing 1 x 10 ml bottle

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • CY00090V
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0124/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 10/05/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."